Xcellerex raises $11,000,000

Xcellerex Inc., a privately held company that manufactures drugs and develops production processes for biotechnology and pharmaceutical companies, has raised $11 million in venture capital The company, which has traditionally focused on producing drugs for other companies’ clinical trials, will use the financing to make and sell drug manufacturing systems known as FlexFactory,